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While historically acetylcholine (ACh) holds a central place in the discovery of chemical
transmission in the nervous system, progress in our knowledge of the mechanistic underpinnings
of cholinergic transmission in the central nervous system (CNS) has lagged behind its sister
transmitters. For example, unlike what we know about glutamatergic transmission, neither the
prevalence of fast cholinergic transmission or postsynaptic specializations at cholinergic synapses,
is well understood. Every level of inquiry into the cholinergic system reveals a bewildering
complexity in signaling and transduction mechanisms. Receptor localizations within and among
neurons, along with transmitter source and access to receptors, provide for a system that is capable
of neuromodulation at multiple time scales that allow for short- and long-term regulation of circuit
output in the brain. The compilation of reviews and primary papers in this research topic provides
a sampling of findings at different levels of integration that highlight both the current status of our
understanding of CNS cholinergic mechanisms as well as reveals the gaps in our knowledge that
need to be filled.
How ACh mediates signaling in the brain is still an unresolved issue at the level of
synaptic physiology. Cholinergic innervation in the brain arises from two main loci- the basal
forebrain and the pendunculo-pontine area of the hindbrain. In both instances a relatively small
cluster of neurons send diffuse projections into various target areas. The diffuse nature of the
projections, as well as the non-planar relationship between the cholinergic neurons and their targets
precludes traditional slice electrophysiology approaches to examining signaling. Recent advances
in optogenetic techniques offer a potential solution to this problem and some of the advances made
thus far are reviewed in this research topic (Luchicchi et al., 2014). Some of the relevant issues that
need to be resolved are the prevalence of synaptic vs. non-synaptic modes of activation, the role of
transmitter diffusion, relationship between ACh release sites and the distribution of acetylcholine
esterases, and the potential co-release of other transmitters from cholinergic terminals.
In addition to the centrifugal cholinergic inputs, areas of the cortex also express their own,
resident, cholinergic interneurons. Well studied among these are the cholinergic interneurons of
the striatum, relevant to disorders like Parkinson’s disease. These are large aspiny neurons that are
small in number (about 1% of the total neuronal population) but send dense projections throughout
the area. Recent findings that are summarized here (Lim et al., 2014) show that these neurons
themselves are subject to complex regulation, both excitatory and inhibitory, from a vast area of
other transmitter systems. Another area, where cholinergic interneurons have been described is
the hippocampus (Frotscher et al., 2000). Thus, far, these neurons have remained an oddity, with
no functional attribution. In this research topic, work done by the group of Josh Lawrence (Yi
et al., 2015) has begun the examination of these neurons using transgenic mice where GFP or YFP
is expressed driven by the choline acetyltransferase promoter. Interestingly, these neurons might
themselves be subject to cholinergic modulation, presumably from basal forebrain innervation.
We have a long way to go before we understand the complex variables of cholinergic signaling.
Differential expression of various subtypes of the ionotropic nicotinic acetylcholine receptors
(nAChRs) and the metabotropic muscarinic acetylcholine receptors (mAChRs), their expression
in multiple neuronal types within a region, and varying locations within a neuron (i.e., somatic,
Vijayaraghavan and Sharma Editorial: Brain cholinergic mechanisms
dendritic, synaptic etc.) all orchestrate a complex symphony of
neuromodulation. A review of receptor localization and function
within hippocampal CA 1 interneurons (McQuiston, 2014)
illustrates how complex expression of the two classes of receptors
can allow for differential control of principal cell activity under
varying concentrations of the transmitter.
These local control mechanisms can regulate circuit outputs
in various regions of the brain, potentially mediating the
attention and learning-specific behaviors ascribed to ACh-driven
modulation. In the olfactory system, nAChR activation can
filter odor signals such that weak inputs are eliminated while
strong ones are allowed through, thus providing a mechanism
for altering the gain function of a circuit (D’Souza and
Vijayaraghavan, 2014) and, perhaps, regulating the effects of
these receptors on odor discrimination (Hellier et al., 2010). In
the visual cortex, differential functional expression of mAChRs
might explain neuronal synchrony and gamma oscillations
allowing for the tuning of network output during tasks involving
perceptual learning (Groleau et al., 2015). In the hippocampus, a
potential role for mAChR-regulated release of endocannabinoid
in circuit oscillation highlight the complex mechanisms in play
that underlie the effects of the cholinergic system in regulation of
behavior (Alger et al., 2014).
Cholinergic receptors are a potential gold mine as targets
for therapies and pharmaceutical companies have not been
diffident about exploring various receptor ligands as potential
therapies. Emerging studies implicate cholinergic receptors
in various addictive mechanisms: the direct interaction
between cocaine and nAChRs reported in this research
topic (Acevedo-Rodriguez et al., 2014) illustrates how these
receptors could play an important role in the reinforcement
properties of cocaine. The cholinergic system appears to be
involved in specific behavioral endophenotypes of a number of
diseases such as Alzheimer’s disease (Oddo and LaFerla, 2006),
schizophrenia (Wallace and Bertrand, 2013), and Parkinson’s
disease (Bohnen et al., 2010). More recent animal model studies
also implicate the transmitter system in autism (Amodeo et al.,
2014).
This is prime time for the development of clinical therapies
that target the cholinergic system for a host of brain disorders.
At the same time, as the collection of studies in this research
topic illustrates, much remains to be understood regarding the
physiology of cholinergic transmission and modulation. There
is a risk of pharmacological advances outpacing our knowledge
of cholinergic signaling mechanisms in the brain. History tells
us that such a disconnect between therapeutic advances and
our knowledge of physiology can often lead to unintended
complications from novel therapies, a classic example being the
aggressive marketing of heroin as a cough remedy at the turn of
the twentieth century. There needs to be significant investment in
examining the basic biology of cholinergic modulation of brain
circuits in order to develop more rational and safe therapeutic
targets that the cholinergic system offers.
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